BIOPORT
LIVE

Serial Number

97913613

Owner

Texas Medical Center

Attorney

Julie Albert

Filing Date

Apr 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BIOPORT Trademark

Serial Number: 97913613

BIOPORT is a trademark filed by Texas Medical Center on April 28, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 43 (Hotels & Restaurants), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Texas Medical Center (46 trademarks)

6th Floor
Houston, TX 77030

Entity Type: 99

Trademark Details

Filing Date

April 28, 2023

Registration Date

Not Registered

Published for Opposition

September 17, 2024

Goods & Services

Contract research organization support services to the medical, health care, pharmaceutical, biotechnology, and medical device industries in the form of scientific and medical research services outsourced on a contract basis in the field of development of biopharmaceuticals and biologic assays; preclinical research, clinical research, and pharmacovigilance services in the nature of pharmacological research and analysis; Providing computer security services in the nature of administering digital certificates for others; Scientific and technological services, namely, scientific research, analysis, testing, in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; scientific consultancy and research services for others in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; technical consultancy for others in the field of computing and engineering; technological consultancy for others in the field of life sciences, physical sciences, and social sciences; technological research, development and design services in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences, namely, pharmaceutical drugs, medical devices, and biotechnological products; industrial design services; industrial research and technological research services in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; scientific study and research in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; industrial research in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; academic technological research in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; scientific research; computer programming services; computerized analysis of data, namely, data automation and collection service using proprietary software to evaluate, analyze and collect service data; technology analysis being technology consultancy services in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; technological services, namely, data analysis in the field of computing and engineering; Technology specification, namely, analyzing technology requirements and developing recommendations for the computer software and systems and other technology needed to meet those requirements, in the fields of computing, life sciences, engineering, physical sciences, and social sciences; analysis of technical data by means of graphics, tables and reports in the field of computing and engineering; scientific analysis of technical data by means of graphics, tables and reports in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; product evaluation services to assure compliance with industry standards; testing and analysis services of products in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences to assure compliance with industry standards; research laboratory analysis in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; new product experimental design and failure analysis in the field of computing, life sciences, engineering and manufacturing, physical sciences, and social sciences; quality control services for others; providing temporary use of online non-downloadable software for accessing, analyzing, reading, and tracking information in the field of education, business development and scientific and industrial research; providing information, advisory and consultancy services in relation to scientific research and technology in the fields of computing, life sciences, engineering and manufacturing, physical sciences and social sciences; Research laboratory data analysis services in the field of pharmaceutical drug manufacturing

Manufacturing services for others in the field of pharmaceutical drugs, medical devices, and biotechnological products; Custom manufacture of pharmaceuticals; manufacturing process consulting

New product commercialization services, namely, commercialization of pharmaceutical drugs, medical devices, and biotechnological products; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of hospitals, academic and research institutions, and biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Promoting collaboration within the scientific, research, medical and pharmaceutical communities to achieve advances in the fields of medicine, health care, science and biomedical engineering for human performance; providing information on the topic of promoting public awareness of improving the performance of scientific, medical and pharmaceutical research by others to achieve advances in the fields of medicine, health care, science and biomedical engineering for human performance; promoting public awareness of the need for collaboration within the scientific, research, medical and pharmaceutical communities to achieve advances in the fields of medicine, health care, science and biomedical engineering for human performance; promoting public awareness of the need for the performance of scientific, medical and pharmaceutical research by others to achieve advances in the fields of medicine, health care, science, and biomedical engineering for human performance; but excluding from all of the foregoing the provision of medical services and the performance of clinical trials or clinical research; Providing business administration services for others

Providing building management services for others

Independent ethics committee review services, namely, reviewing standards and practice to ensure compliance with laws and regulations concerning the ethics of biomedical and medical research testing on human subjects; independent ethical review of biomedical research and medical research on human subjects to ensure compliance with ethics laws and regulations concerning the same; providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure compliance with laws and regulations concerning the ethics of biomedical and medical research testing on human subjects; providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; Providing security guard services for others

Providing temporary housing accommodations for others

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 23, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 22, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 22, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 22, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 20, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 20, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 20, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2025 EX1G
SOU EXTENSION 1 FILED
Jan 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 2, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 2, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 2, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 2, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 29, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 29, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 29, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 29, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2023 NWOS
NEW APPLICATION ENTERED
May 2, 2023 NWAP